Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Federal Trade Commission
Daiichi Sankyo
Queensland Health
Accenture
Johnson and Johnson
Moodys
Healthtrust

Generated: October 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209724

« Back to Dashboard

NDA 209724 describes BUMETANIDE, which is a drug marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Ivax Sub Teva Pharms, Sandoz, Upsher-smith Labs, and Zydus Pharms Usa Inc, and is included in ten NDAs. It is available from nineteen suppliers. Additional details are available on the BUMETANIDE profile page.

The generic ingredient in BUMETANIDE is bumetanide. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 209724
Tradename:BUMETANIDE
Applicant:Amneal Pharms Co
Ingredient:bumetanide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209724
Medical Subject Heading (MeSH) Categories for 209724
Suppliers and Packaging for NDA: 209724
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUMETANIDE bumetanide TABLET;ORAL 209724 ANDA NuCare Pharmaceuticals,Inc. 68071-4330 68071-4330-3 30 TABLET in 1 BOTTLE (68071-4330-3)
BUMETANIDE bumetanide TABLET;ORAL 209724 ANDA NuCare Pharmaceuticals,Inc. 68071-4330 68071-4330-6 60 TABLET in 1 BOTTLE (68071-4330-6)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Fish and Richardson
Chubb
Covington
Harvard Business School
Queensland Health
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.